RA Capital Healthcare Fund LP's Sale of Vor Biopharma Inc. Common Stock

RA Capital Healthcare Fund LP, a 10% stockholder and director of Vor Biopharma Inc., has filed a Form 144 notice indicating the intent to sell 76,919 shares of common stock. The shares were acquired through private financing transactions between February 2019 and February 2021. The aggregate market value of the shares to be sold is approximately $2,263,726.17. Additionally, RA Capital Healthcare Fund LP has sold a significant amount of Vor Biopharma Inc. common stock in the past three months, totaling 387,863 shares with gross proceeds exceeding $11.45 million. The sales were executed through BTIG, LLC, a broker based in San Francisco.